MDR 1.89% 54.0¢ medadvisor limited

Ann: Q4 FY24 MDR Quarterly Update, page-4

  1. 2,908 Posts.
    lightbulb Created with Sketch. 1086
    I think you have to take a look at their business beyond one quarter because the US business revenues tend to be skewed to the quarters ending in Sep & Dec (well Dec is make/break).

    For FY2024 they were $5m cashflow positive because they brought in $15m in that Dec quarter. It would be good for them to pay back the loan they have, but between investment which grows top line at 25% per annum and gross profit at a similar rate (hopefully more if they can improve margins), then to me it seems appropriate to make that $10-15m investment especially if it's funded from growth and puts them in a stronger position against competition (especially given the scale of the market in the US and also how they have managed to expand into adjacencies in Australia)
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
(20min delay)
Last
54.0¢
Change
0.010(1.89%)
Mkt cap ! $297.2M
Open High Low Value Volume
53.0¢ 54.0¢ 50.0¢ $145.1K 281.5K

Buyers (Bids)

No. Vol. Price($)
1 60000 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
54.0¢ 21119 2
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.